Prenatal Diagnosis and Intrapartum Management of Congenital Ranula

Ercan, Fedi; Sarikaya, Müslüm; Toprak, Erzat; Fındık, Sıddıka; Arbağ, Hamdi; Acar, Ali

doi:10.1055/a-0660-9808

Cited by 8 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The baby is delivered after this process is achieved. Once the patient’s health has stabilised, a postnatal evaluation is undertaken to determine the most definitive therapy for the ranula 3 15 16…”

Section: Discussionmentioning

confidence: 99%

Outlandish manifestation of swelling in early childhood seen in the patient’s floor of the mouth

Kaggare Puttaraju,

Manjunatha,

Niranjan

2024

BMJ Case Rep

View full text Add to dashboard Cite

Ranula is a cyst-like growth that occurs in the oral cavity beneath the tongue. It consists of saliva from a ruptured salivary gland or duct. Rather than just flowing directly from the glands into the oral cavity, saliva permeates the nearby connective tissues and creates a bubble. A ranula could indeed appear at any time span in a person’s life for inexplicable reasons. A trauma such as an oral operation, a facial blow or nibbling the lower lip may possibly start one. The following is a case study of an early childhood boy who reported with a swelling in the floor of the mouth with unknown aetiology from the last 6 months.

show abstract

Section: Discussionmentioning

confidence: 99%

Outlandish manifestation of swelling in early childhood seen in the patient’s floor of the mouth

Kaggare Puttaraju,

Manjunatha,

Niranjan

2024

BMJ Case Rep

View full text Add to dashboard Cite

show abstract

“…The primary goal is to provide a safe airway in the neck, face and mediastinum pathologies that cause full obstruction in the early postnatal period by damaging or compressing the airway structures. The use of the EXIT procedure to facilitate airway safety in a controlled manner while placental circulation continues, has been proposed as an optimal administration strategy for patients with such pathologies (9)(10)(11)(12)(13)(14)(15) . With EXIT procedure, the reported survival becomes 50% for tracheal atresia and 94% for laryngeal atresia.…”

Section: Discussionmentioning

confidence: 99%

Prenatal Tanılı Servikal Kitleye Ekstrauterin İntrapartum Tedavi ((EXIT) Yöntemiyle Yaklaşım

Özcan¹,

Karagöz²,

Hakalmaz³

et al. 2022

JTAPS

View full text Add to dashboard Cite

A patient with prenatal diagnosis of a cervical mass compressing the trachea managed by the the exutero intrapartum treatment (EXIT) at birth was detailed. The patient had presented with polyhydramnios and a cervical mass during the prenatal period. At the thirty-seventh gestational week, decision was given to perform the delivery with the EXIT procedure. The baby was delivered by cesarean section under general anesthesia, with the entire team ready to be sterile intraoperatively. The baby was intubated oropharyngeally without clamping the cord to preserve uteroplacental and placento-fetal circulation. The cord was then clamped and the patient taken to the neonatal intensive care unit under stable condition. On the 2nd postnatal day, cervical CT showed a 65x65x55 mm solid mass lesion, which was totally excised on the 3rd postnatal day.Histopathological examination revealed an immature teratoma. The patient is well and without any clinical problem in the 3th postoperative year of follow-up. The EXIT procedure is an effective treatment option in cervical masses that cause severe airway obstruction during the prenatal period, as it preserves placentofetal circulation until safe airway is achieved. Multidisciplinary approach and planning is required for safe performance of this advanced perinatal resuscitation technique.

show abstract

“…The differential diagnosis of oro-cervical masses includes teratoma, ranula, palatal cysts, epidermoid cysts, congenital epulides, dermoid cysts, lymphatic malformation and haemangiomas [9] (Table 1). Though all lesions are benign, their location can have different effects on the clinical course and outcome.…”

Section: Discussionmentioning

confidence: 99%

Prenatal 2-D and 3-D Ultrasound Characteristics of a Case of Fetal Orofacial Macrocystic Lymphatic Malformation and its Postnatal Management with Intralesional Bleomycin

Elango¹,

Subramani

Saranyadevi³

et al. 2022

Journal of Fetal Medicine

View full text Add to dashboard Cite

Fetal lymphatic malformations (FLM) are benign hamartomatous lesions of the lymphatic vasculature usually localized in the cervicofacial and axillary regions and less frequently in the abdomen or inguinal areas, with an overall incidence of 1:6000 to 1:16,000 live births. FLM has a potential association with chromosomal aneuploidies such as Trisomy 21,18,13, Turner syndrome and genetic conditions such as Noonan syndrome, and with an excess risk for co-existing structural defects. A progressive increase in the dimensions of FLM's may result in polyhydramnios, hydrops, intrauterine fetal demise, airway obstruction and neonatal respiratory distress. We report a case of fetal orofacial lymphatic malformation detected in the mid-trimester anomaly scan with details of two-and three-dimensional imaging, prenatal counseling, cytogenetic workup, serial ultrasound surveillance, postnatal magnetic resonance imaging, and management with an intra-lesional sclerosing agent. The case depicts the strategic importance of multidisciplinary inputs in managing cases of prenatally diagnosed oral-cervical masses for optimizing perinatal outcome.

show abstract

Prenatal Diagnosis and Intrapartum Management of Congenital Ranula

Cited by 8 publications

References 13 publications

Outlandish manifestation of swelling in early childhood seen in the patient’s floor of the mouth

Outlandish manifestation of swelling in early childhood seen in the patient’s floor of the mouth

Prenatal Tanılı Servikal Kitleye Ekstrauterin İntrapartum Tedavi ((EXIT) Yöntemiyle Yaklaşım

Prenatal 2-D and 3-D Ultrasound Characteristics of a Case of Fetal Orofacial Macrocystic Lymphatic Malformation and its Postnatal Management with Intralesional Bleomycin

Contact Info

Product

Resources

About